Geron | GERN - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Amgen USD 20.83B 17.97B 2026-09
Bio Techne USD 26.7M 68.9M 2026-06
Cassava Sciences USD 39.29M 102K 2026-06
Cytokinetics USD 25.96M 5.45M 2026-09
Exelixis USD 30.83M 8.23M 2026-09
Genmab DKK 116M 110M 2026-06
Geron USD 15.46M 6.66M 2026-09
Gilead Sciences USD 934M 260M 2026-09
Incyte USD 235.37M 1.16B 2026-09
MacroGenics USD 3.44M 845K 2026-06
Novartis USD 4.24B 15M 2026-09
Novavax USD 24.94M 2.01M 2026-09